Drugs / Cadumilimab
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06345599 | May 2024 → Jan 2027 expected | pancreatic ductal adenocarcinoma | Second Affiliated Hospital of Soochow University | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cadumilimab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06345599 ↗ |